Literature DB >> 24018070

Is laparoscopy a risk factor for bile duct injury during cholecystectomy?

Terrence M Fullum1, Stephanie R Downing, Gezzer Ortega, David C Chang, Tolulope A Oyetunji, Kendra Van Kirk, Daniel D Tran, Ian Woods, Edward E Cornwell, Patricia L Turner.   

Abstract

BACKGROUND AND OBJECTIVES: Previously, risk factors for bile duct injury have been identified as acute cholecystitis, male gender, older age, aberrant biliary anatomy, and laparoscopic cholecystectomy.
METHODS: A retrospective analysis of the Nationwide Inpatient Sample from 1998 to 2006 was performed with an inclusion criterion of cholecystectomy performed on hospital day 0 or 1. Patient- and hospital-level factors potentially associated with bile duct injury were examined by logistic regression.
RESULTS: A total of 377,424 cholecystectomy patients were identified. There were 1124 bile duct injuries (0.30%), with 177 (0.06%) in the laparoscopic cholecystectomy group and 947 (1.46%) in the open cholecystectomy group (P < .001). On multivariate analysis, significant risk factors for bile duct injury were male gender (odds ratio [OR], 1.21; 95% confidence interval [CI], 1.06-1.38; P = .006), age >60 years (OR, 2.23; 95% CI, 1.61-3.09; P < .001), and academic hospital status (OR, 1.37; 95% CI, 1.05-1.79; P = .02). Acute cholecystitis was associated with a lower risk of bile duct injury (OR, 0.67; 95% CI, 0.46-0.99; P = .044).
CONCLUSION: Independent risk factors for bile duct injury included male gender, age >60 years, and academic hospital status. Laparoscopic cholecystectomy, obesity, insurance status, or hospital volume was not associated with an increased risk of bile duct injury.

Entities:  

Mesh:

Year:  2013        PMID: 24018070      PMCID: PMC3771752          DOI: 10.4293/108680813X13654754535638

Source DB:  PubMed          Journal:  JSLS        ISSN: 1086-8089            Impact factor:   2.172


INTRODUCTION

Each year, more than 400,000 patients undergo a cholecystectomy, most commonly to treat symptomatic cholelithiasis.[1] Though reported to be uncommon, an iatrogenic bile duct injury (BDI) during a cholecystectomy is a serious complication associated with significant morbidity and death.[2-4] Reports in the early 1990s identified laparoscopic cholecystectomy (LC) as a risk factor for BDI.[3,5-8] Several reasons for this phenomenon were cited, the most common being the “learning curve” of a new and technically demanding skill.[9] Subsequently, articles were published describing recommended techniques to reduce BDI during LC. Notable articles included reports by Hunter[10] recommending the use of a 30° laparoscope and avoidance of tenting; Strasberg,[11] who advocated the use of a “critical view” approach; and Kato et al.,[12] who introduced the “dome down” LC. Over the next 15 to 20 years, LC became the standard of care and surgeon experience with minimally invasive techniques increased dramatically. As a result, there has been a significant reduction in the BDI rate, from 0.5% in 1990 to 0.3% in 2009.[4,7] By use of a large population-based dataset, analyses were performed to identify current risk factors for BDI. Specifically, a multivariate analysis was used to determine whether LC was still a risk factor for BDI. We hypothesize that LC is no longer a predictor of BDI based on the assumption that many surgeons have already surpassed the learning curve.

METHODS

A 9-year retrospective analysis was performed of the Nationwide Inpatient Sample (NIS) from 1998 through 2006. The NIS was developed as part of the Healthcare Cost and Utilization Project sponsored by the Agency for Healthcare Research and Quality, established by the federal government. The NIS contains discharge records from 1045 hospitals in 38 states, comprising almost 8 million admissions per year. It is a systematically randomized sample of 20% of all patients admitted to hospitals in the United States. The inclusion criterion was any record with cholecystectomy as the primary procedure code (International Classification of Diseases, Ninth Revision [ICD-9] codes 51.22 [LC] and 51.23 [open cholecystectomy (OC)]) performed on hospital admission day 0 or 1. Procedure codes for bile duct repair (ICD-9 codes 51.36, 51.37, 51.39, 51.71, 51.72, and 51.79) were used as a surrogate for BDI. Patient- and hospital-level factors that were potentially associated with BDI were examined by use of a multivariate analysis. These included age, race, gender, morbid obesity (ICD-9 code 278.01), diagnosis of acute cholecystitis (ICD-9 code 87.50), performance of intraoperative cholangiography (ICD-9 code 87.53), insurance status, academic hospital status, year of procedure (as a surrogate for the impact of time), and hospital annual volume of cholecystectomy. The Charlson comorbidity index was used to adjust for the impact of patient comorbid conditions on risk of death and development of postoperative complications. The Student t test (for continuous variables) and χ2 test (for nominal or categorical variables) were used for all bivariate analyses. Adjusted analyses using multiple logistic regressions were performed to determine the independent impact of these variables on the risk of a BDI developing after cholecystectomy. Subset analyses were repeated in patients with acute cholecystitis. All statistical analyses were performed with Stata MP, version 10 (StataCorp, College Station, TX, USA).

RESULTS

A total of 377,424 cholecystectomy patients were identified, of whom 312,522 (82.8%) underwent LC and 64,902 (17.2%) underwent OC. Demographics of these patients are shown in . The mean age at presentation was 51 years, and 70.0% of patients were women. Morbid obesity was a comorbid diagnosis for 2.3% of cholecystectomy patients, with a slightly higher percentage (3.9%) diagnosed with acute cholecystitis. Represented ethnicities were white patients (70.8%), black patients (8.2%), Hispanic patients (15.7%), and patients of other ethnicities (5.3%). Intraoperative cholangiography was performed in 23.5% of the study population. The overall BDI rate was 0.30% (n = 1124). shows the bivariate (unadjusted) analysis by intervention (OC vs LC). Patients who underwent OC were significantly older than those undergoing LC (58.4 years vs 50.0 years, P < .001), with an associated increase in length of stay compared with LC patients (5.4 days vs 2.4 days, P < .001). Those more likely to undergo OC were men (24.51% vs 14.12% of women, P < .001), black patients (18.87% vs 17.55% of white patients, P < .001), morbidly obese patients (21.96% vs 17.08% of patients who were not morbidly obese, P < .001), and patients with acute cholecystitis (24.63% vs 16.90% of patients without acute cholecystitis, P < .001). shows the increasing proportion of LC compared with OC over the study period. Demographics of Patients Who Underwent Cholecystectomy in NIS Bivariate Analysis by Type of Intervention for Patients Who Underwent Cholecystectomy in NIS Proportion of cases performed by approach and year of study. The bivariate analysis of risk of BDI is shown in . Patients who had a BDI were significantly older than those who had an uneventful cholecystectomy (59.3 years vs 51.4 years, P < .001). Those patients who had a BDI had a longer length of stay than uninjured patients (8.1 days vs 2.9 days, P < .001). Men also had a higher incidence of BDI compared with women (0.38% vs 0.27%, P < .001). The proportion of OCs performed showed a statistically significant decrease, from 19.5% in the initial 3 years of the study to 15.1% in the past 3 years (P < .001). Furthermore, during the same periods, there was a decrease in the overall incidence of documented BDI (0.33% in 1998–2000 vs 0.27% in 2004–2006, P = .02) (). Bivariate Analysis by Injury for Patients Who Underwent Cholecystectomy in NIS Incidence of BDI. The adjusted analysis for the risk of BDI is shown in . Male gender (odds ratio [OR], 1.23; 95% confidence interval [CI], 1.07–1.41; P = .003), age >60 years (OR, 2.31; 95% CI, 1.64–3.25; P < .001), and treatment received at a teaching institution (OR, 1.35; 95% CI, 1.04–1.76; P = .026) were all associated with increased odds of BDI. LC, however, was not an independent predictor of BDI. Other factors (ethnicity, obesity, insurance status, diagnosis of acute cholecystitis, and hospital volume) were also not associated with the risk of BDI. Multivariate Logistic Regression for Risk of BDI Among Patients Who Underwent Cholecystectomy in NIS shows the multivariate logistic regression for increased odds of death after cholecystectomy in patients. Again, male gender (OR, 1.29; 95% CI, 1.14–1.45; P < .001) and age >60 years (OR, 7.90; 95% CI, 4.31–14.47; P < .001) were independently associated with an increased odds of death. Other predictors of death were the diagnosis of acute cholecystitis (OR, 2.32; 95% CI, 1.90–2.83; P < .001) and presence of BDI (OR, 2.37; 95% CI, 1.36–4.12; P < .001). Multivariate Logistic Regression for Risk of Death Among Patients Who Underwent Cholecystectomy in NIS

DISCUSSION

This study showed that BDI was significantly associated with male gender, age >60 years, and treatment received at a teaching institution. LC and a diagnosis of acute cholecystitis, however, were not associated with increased odds of BDI. The increased risk of BDI in men could not be explained in our study. This may reflect socioeconomic influences that are difficult to discern from a large database review. Despite numerous studies showing the differences in cancer[13-16] and trauma[17-20] care by socioeconomic and insurance status, there was no indication that insurance status impacted BDI rates. The increased risk of BDI in teaching institutions may be associated with the complexities of patients treated at these centers or the learning curve associated with resident training (or both).[21,22] Interestingly, BDI was not associated with a diagnosis of acute cholecystitis. In fact, there was a lower risk of BDI with acute cholecystitis in both LC and OC subsets. Furthermore, no significant decrease in the risk of BDI with increasing hospital volume was found. This finding and the fact that LC was not an independent risk factor for BDI may also support the concept that the era of current practice has surpassed the learning curve. After we controlled for other factors, LC was shown to be associated with a reduced risk of BDI. However, these results should be interpreted against the backdrop of data collection methodology for the NIS. First, the NIS does not capture the repair of BDIs for patients who were diagnosed after discharge after their initial treatment. Because the length of stay is shorter for LC over OC, it may be possible that some of these (delayed diagnosis) BDI patients would be within the LC group. Furthermore, because the NIS does not code by intent of operation, if a BDI was noticed during the initial operation and the surgeon converted an LC to an open approach for repair, the operation may be coded as an OC. Despite this fact, the total number of BDIs decreased over time. The adjusted risk of death after cholecystectomy still echoed as a risk factor for BDI, even after we controlled for the presence of such an injury and comorbid conditions in the Charlson index. Male patients, patients aged >60 years, and patients who had a BDI all showed an independent increased risk of death. Although patients diagnosed with acute cholecystitis were not found to be at an increased risk of BDI, they were at an increased risk of death. Variables not associated with an increased risk of death included patient ethnicity, insurance status, morbid obesity, hospital teaching status, and hospital volume. Limitations to this study are those of any retrospective or administrative-based study. As noted earlier, the only patients captured were those diagnosed with a BDI during the same hospital stay. Any patients with a missed BDI that was diagnosed during a subsequent hospitalization would not have been included. Finally, a selection bias existed with these data; those patients who underwent OC likely did so because of safety considerations. These patients likely had anatomic or physiological barriers that prohibited the surgeon from performing a safe LC and therefore put them at higher risk for BDI during OC as well. Despite these limitations, the results show that the percentage of cholecystectomies performed laparoscopically has increased over the 9-year period of the study whereas the rate of BDI has decreased over the same period.

CONCLUSIONS

Male gender, age >60 years, and treatment in a teaching hospital are all independent risk factors for BDI. Male gender and age >60 years were also risk factors for death after cholecystectomy. Having a BDI or being diagnosed with acute cholecystitis was an additional independent risk factor for death after cholecystectomy. LC, patient ethnicity, insurance status, diagnosis of morbid obesity, and patient hospital volume were not associated with either risk of BDI or risk of death. In this study laparoscopy was not found to be a risk factor for BDI during cholecystectomy. The overall rate of BDI has decreased over time, whereas the rate of LC has increased. These results may reflect increased knowledge and experience with laparoscopic techniques, particularly LC. We believe that the overall learning curve is diminishing as resident teaching methods and experience in laparoscopy improve.
Table 1.

Demographics of Patients Who Underwent Cholecystectomy in NIS

Data
No. of patients377,424
Median age, y51
Mean LOS, d2.8
Gender, n (%)
    Male112,951 (30.0)
    Female262,985 (70.0)
Ethnicity, n (%)
    White225,511 (70.8)
    Black25,963 (8.2)
    Hispanic49,887 (15.7)
    Other17,312 (5.4)
Inflammation, n (%)
    Acute cholecystitis14,650 (3.9)
    No acute cholecystitis362,774 (96.1)
Obesity, n (%)
    Not morbidly obese368,653 (97.7)
    Morbidly obese8,771 (2.3)
Intervention, n (%)
    OC64,902 (17.2)
    LC312,522 (82.8)
Year of surgery, n (%)
    1998–2000127,244 (33.7)
    2001–2003129,783 (34.4)
    2004–2006119,273 (31.9)
Table 2.

Bivariate Analysis by Type of Intervention for Patients Who Underwent Cholecystectomy in NIS

OCLCP Value
No. of patients (%)64,902 (17.20)312,522 (82.80)
Mean age, y58.450.0<.001
Mean LOS, d5.42.4<.001
Gender, n (%)<.001
    Male27,679 (24.51)85,272 (75.49)
    Female37,136 (14.12)225,849 (85.88)
Ethnicity, n (%)<.001
    White39,580 (17.55)185,931 (82.45)
    Black4,899 (18.87)21,064 (81.13)
    Hispanic6,795 (13.62)43,092 (86.38)
    Other2,795 (16.10)14,517 (83.90)
Weight, n (%)<.001
    Not morbidly obese62,976 (17.08)305,677 (82.92)
    Morbidly obese1,926 (21.96)6,845 (78.08)
Inflammation, n (%)<.001
    No acute cholecystitis61,293 (16.90)301,481 (83.10)
    Acute cholecystitis3,609 (24.63)11,041 (75.37)
Year of surgery, n (%)<.001
    1998–200024,581 (19.32)102,663 (80.68)
    2001–200321,588 (16.63)108,195 (83.37)
    2004–200617,786 (14.91)101,487 (85.09)
Table 3.

Bivariate Analysis by Injury for Patients Who Underwent Cholecystectomy in NIS

BDINo BDIP Value
No. of patients (%)1,124 (0.30)376,300 (99.70)
Mean age, y59.351.4<.001
Mean LOS, d8.12.9<.001
Gender, n (%)<.001
    Male699 (0.38)112,526 (99.62)
    Female425 (0.27)262,286 (99.73)
Ethnicity, n (%)<.001
    White694 (0.31)224,817 (99.69)
    Black67 (0.26)25,896 (99.74)
    Hispanic110 (0.22)49,777 (99.78)
    Other77 (0.44)17,235 (99.56)
Weight, n (%).071
    Not morbidly obese1,107 (0.30)367,546 (99.70)
    Morbidly obese17 (0.19)8,754 (99.81)
Inflammation, n (%).051
    No acute cholecystitis1,093 (0.30)361,681 (99.70)
    Acute cholecystitis31 (0.21)14,619 (99.79)
Intervention, n (%)<.001
    LC177 (0.06)312,345 (99.94)
    OC947 (1.46)63,955 (98.54)
Year of surgery, n (%).02
    1998–2000423 (0.33)126,821 (99.67)
    2001–2003375 (0.29)129,408 (99.71)
    2004–2006266 (0.27)119,007 (99.73)
Table 4.

Multivariate Logistic Regression for Risk of BDI Among Patients Who Underwent Cholecystectomy in NIS

OR95% CIP Value
Age
    <25 y1.00Referent
    25–40 y1.010.69–1.47.970
    40–60 y1.200.84–1.71.308
    >60 y2.311.64–3.25<.001
Gender
    Female1.00Referent
    Male1.231.07–1.41.003
Ethnicity
    White1.00Referent
    Black0.940.72–1.23.649
    Hispanic0.940.73–1.20.612
    Other1.010.33–3.05.991
Weight
    Not morbidly obese1.00Referent
    Morbidly obese0.520.26–1.05.068
Inflammation
    No cholecystitis1.00Referent
    Cholecystitis0.700.47–1.04.081
Insurance status
    Uninsured1.00Referent
    Insured1.660.24–11.26.604
Hospital factors
    Non-teaching hospital1.00Referent
    Teaching hospital1.351.04–1.76.026
Volume1.001.00–1.00.838
Table 5.

Multivariate Logistic Regression for Risk of Death Among Patients Who Underwent Cholecystectomy in NIS

OR95% CIP Value
Injury
    No BDI1.00Referent
    BDI2.371.36–4.12.002
Age
    <25 y1.00Referent
    25–40 y1.120.58–2.18.738
    40–60 y1.520.82–2.82.182
    >60 y7.904.31–14.47<.001
Gender
    Female1.00Referent
    Male1.291.15–1.45<.001
Ethnicity
    White1.00Referent
    Black1.210.95–1.54.123
    Hispanic0.870.70–1.08.196
    Other0.780.26–2.31.648
Weight
    Not morbidly obese1.00Referent
    Morbidly obese0.720.43–1.19.197
Inflammation
    No cholecystitis1.00Referent
    Cholecystitis2.321.90–2.83<.001
Hospital factors
    Non-teaching hospital1.00Referent
    Teaching hospital1.070.93–1.23.346
Volume1.001.00–1.00.076
  22 in total

1.  Serious complications of laparoscopic cholecystectomy in New York State.

Authors:  R P Nenner; P J Imperato; C M Alcorn
Journal:  N Y State J Med       Date:  1992-05

2.  Avoidance of bile duct injury during laparoscopic cholecystectomy.

Authors:  J G Hunter
Journal:  Am J Surg       Date:  1991-07       Impact factor: 2.565

3.  Chief resident experience with laparoscopic cholecystectomy.

Authors:  G S Ferzli; M A Fiorillo; N E Hayek; F Sabido
Journal:  J Laparoendosc Adv Surg Tech A       Date:  1997-06       Impact factor: 1.878

4.  Laparoscopic cholecystectomy-associated bile duct injuries.

Authors:  B E Stabile
Journal:  West J Med       Date:  1998-01

5.  Laparoscopic cholecystectomy from fundus downward.

Authors:  K Kato; M Matsuda; K Onodera; T Kobayashi; S Kasai; M Mito
Journal:  Surg Laparosc Endosc       Date:  1994-10

6.  Accidental lesions of the common bile duct at cholecystectomy. Pre- and perioperative factors of importance.

Authors:  A Andrén-Sandberg; G Alinder; S Bengmark
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

7.  Insurance type is a determinant of 2-year mortality after non-neurologic trauma.

Authors:  Ben L Zarzaur; Brad R Stair; Louis J Magnotti; Martin A Croce; Timothy C Fabian
Journal:  J Surg Res       Date:  2009-08-21       Impact factor: 2.192

8.  Iatrogenic bile duct injuries. The real incidence and contributing factors--implications for laparoscopic cholecystectomy.

Authors:  L Caputo; D R Aitken; M C Mackett; A E Robles
Journal:  Am Surg       Date:  1992-12       Impact factor: 0.688

Review 9.  Avoidance of biliary injury during laparoscopic cholecystectomy.

Authors:  Steven M Strasberg
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

10.  Iatrogenic injury to the bile duct. Who, how, where?

Authors:  A R Moossa; A D Mayer; B Stabile
Journal:  Arch Surg       Date:  1990-08
View more
  14 in total

1.  Age and Obesity are Independent Predictors of Bile Duct Injuries in Patients Undergoing Laparoscopic Cholecystectomy.

Authors:  Hassan Aziz; Viraj Pandit; Bellal Joseph; Tun Jie; Evan Ong
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

2.  Unrecognized right posterior biliary duct: an intra-operative finding.

Authors:  Giovanni Vennarecci; Giovanni Battista Levi Sandri; Lidia Colace; Giuseppe Maria Ettorre
Journal:  Surg Radiol Anat       Date:  2014-02-16       Impact factor: 1.246

3.  Laparoscopic Repair of Post-cholecystectomy Bile Duct Injury: an Advance in Surgical Management.

Authors:  Safi Dokmak; Najat Amharar; Béatrice Aussilhou; François Cauchy; Alain Sauvanet; Jacques Belghiti; Olivier Soubrane
Journal:  J Gastrointest Surg       Date:  2017-03-27       Impact factor: 3.452

4.  Increasing resident utilization and recognition of the critical view of safety during laparoscopic cholecystectomy: a pilot study from an academic medical center.

Authors:  Crystal B Chen; Francesco Palazzo; Stephen M Doane; Jordan M Winter; Harish Lavu; Karen A Chojnacki; Ernest L Rosato; Charles J Yeo; Michael J Pucci
Journal:  Surg Endosc       Date:  2016-08-05       Impact factor: 4.584

Review 5.  Treatment of the iatrogenic lesion of the biliary tree secondary to laparoscopic cholecystectomy: a single center experience.

Authors:  Alessandro Tropea; Duilio Pagano; Antonio Biondi; Marco Spada; Salvatore Gruttadauria
Journal:  Updates Surg       Date:  2016-03-10

6.  Biliary cirrhosis and sepsis are two risk factors of failure after surgical repair of major bile duct injury post-laparoscopic cholecystectomy.

Authors:  L Sulpice; S Garnier; M Rayar; B Meunier; K Boudjema
Journal:  Langenbecks Arch Surg       Date:  2014-05-06       Impact factor: 3.445

7.  Is intraoperative cholangiography necessary during laparoscopic cholecystectomy for cholelithiasis?

Authors:  Guo-Qian Ding; Wang Cai; Ming-Fang Qin
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

8.  Early versus delayed reconstruction for bile duct injury a multicenter retrospective analysis of a hepatopancreaticobiliary group.

Authors:  Danny Conde Monroy; Paula Torres Gómez; Carlos Eduardo Rey Chaves; Andrea Recamán; Manuel Pardo; Juan Carlos Sabogal
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

9.  The critical view of safety during laparoscopic cholecystectomy: Strasberg Yes or No? An Italian Multicentre study.

Authors:  Lucia Ilaria Sgaramella; Angela Gurrado; Alessandro Pasculli; Nicola de Angelis; Riccardo Memeo; Francesco Paolo Prete; Stefano Berti; Graziano Ceccarelli; Marco Rigamonti; Francesco Giuseppe Aldo Badessi; Nicola Solari; Marco Milone; Fausto Catena; Stefano Scabini; Francesco Vittore; Gennaro Perrone; Carlo de Werra; Ferdinando Cafiero; Mario Testini
Journal:  Surg Endosc       Date:  2020-08-11       Impact factor: 4.584

10.  Bile duct reconstruction following laparoscopic cholecystectomy in England.

Authors:  Y El-Dhuwaib; J Slavin; D J Corless; I Begaj; D Durkin; M Deakin
Journal:  Surg Endosc       Date:  2016-01-29       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.